Structure Therapeutics announced it will present multiple posters on its investigational obesity drug Aleniglipron at ObesityWeek 2026 from November 14-17. Aleniglipron is an oral small molecule targeting the GLP-1 receptor, designed for chronic weight management. The presentations will cover trial data including dose-ranging effects and an open-label extension study. This highlights the company's progress in developing scalable oral treatments for obesity, potentially offering an accessible alternative to injectable therapies.
Structure Therapeutics' upcoming presentations at ObesityWeek 2026 provide context for health sector activity on Pluang. Of 150 priced US health stocks, 87 rose and 62 fell today. Notable movers include TNGX at USD 23.60 with a 7.08% increase and a typical hold time of 5 days, ABCL at USD 11.80 down 6.94% with 100% sell order activity, and SMMT at USD 15.60 up 6.63% with balanced buy/sell orders. Data is as of Oct 20, 2026 03:02 WIB.
ICICI Bank reported a 20.1% year-over-year rise in standalone profit after tax to INR 148.43 billion for Q2 FY2027, surpassing earnings estimates with ADR earnings of $0.44 per share versus $0.41 expected. Revenue slightly exceeded forecasts at $3.52...
RTX Corporation is set to release its Q3 2026 earnings report on October 20, with Wall Street expecting earnings of $1.78 per share and revenue around $24.1 billion. The company has a strong record of beating earnings estimates for four consecutive q...
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
